Enrollment temporarily suspended for Epizyme’s tazemetostat trial
On Monday, April 23, the United States Food and Drug Administration (FDA) issued a temporary clinical hold, meaning a pause … Continue reading
Category Archives: Research
New funding opportunity offered in partnership with the Canadian Cancer Society
Our collaboration with the Canadian Cancer Society (CCS), initiated in 2017, progressed last month with the announcement of a new … Continue reading
Chordoma Foundation Biobank Collaborates with Children’s Hospital of Philadelphia
Last fall, the Chordoma Foundation launched a groundbreaking collaboration with Children’s Hospital of Philadelphia (CHOP), one of the nation’s leading … Continue reading
New funding opportunity: Therapeutic Innovation Award
The Chordoma Foundation is pleased to announce an exciting new funding opportunity aimed at accelerating the development of drug therapies … Continue reading
Accelerating drug therapies from the bench to the clinic
Thanks to the robust scientific infrastructure built by the Chordoma Foundation over the last decade, chordoma research is thriving. With … Continue reading
New clinical trial opens testing targeted cancer therapy, palbociclib
A new clinical trial has opened for chordoma patients with locally advanced or metastatic tumors testing the effectiveness of a … Continue reading
First Director of Research recruited to accelerate therapeutic development
A new phase is beginning in our mission to lead the search for better treatments, and ultimately a cure, for … Continue reading
Progress in chordoma research serves as a template for other rare cancers
Since the Chordoma Foundation started, we have been driven by the belief that success in enabling and accelerating research for … Continue reading
Results of the Chordoma Genome Project reveal genetic changes that drive chordoma
Why mutations matter All cancers are the result of abnormal changes (“mutations”) in DNA which cause uncontrolled growth of the … Continue reading
Definitive textbook on chordoma gets an update
“Significant advances have occurred in the last two decades, both in our understanding of the basic pathology and molecular biology … Continue reading